Hemant Surgical Industries Limited (BOM:543916)
India · Delayed Price · Currency is INR 350.95
+9.20 (2.69%)
At close: Aug 21, 2026
BOM:543916 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 438.37 | 95.47 | 131.71 | 84.57 | 58.26 |
Cash & Short-Term Investments | 438.37 | 95.47 | 131.71 | 84.57 | 58.26 |
Cash Growth | 359.17% | -27.51% | 55.74% | 45.16% | 284.16% |
Accounts Receivable | 673.5 | 203.82 | 217.37 | 171.98 | 156.55 |
Other Receivables | - | 1.1 | 0.88 | 0.68 | - |
Receivables | 763.2 | 204.92 | 218.24 | 172.66 | 156.55 |
Inventory | 590.5 | 431.36 | 210.5 | 148.07 | 128.43 |
Prepaid Expenses | - | 5.73 | 2.35 | - | - |
Other Current Assets | 132.1 | 150.48 | 130.16 | 61.85 | 32.99 |
Total Current Assets | 1,924 | 887.95 | 692.96 | 467.14 | 376.23 |
Property, Plant & Equipment | 534.45 | 518.1 | 176.62 | 131.52 | 115.73 |
Long-Term Investments | - | 12.52 | 49.28 | 3.62 | 8.19 |
Long-Term Deferred Tax Assets | 7.86 | 1.63 | - | - | - |
Other Long-Term Assets | 50.09 | 62.88 | 47.51 | 44.65 | 43.61 |
Total Assets | 2,743 | 1,483 | 966.37 | 646.93 | 543.76 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 713.11 | 389.83 | 246.06 | 241.88 | 206.94 |
Accrued Expenses | - | 68.02 | 49.22 | 49.13 | 43.47 |
Short-Term Debt | 467.81 | 23.92 | 21.5 | 24.17 | 44.29 |
Current Portion of Long-Term Debt | - | 53.06 | 10.61 | 16.43 | 12.29 |
Current Income Taxes Payable | - | 12.04 | 4.82 | 10.23 | 7.46 |
Other Current Liabilities | 150.01 | 65.68 | 45.71 | 34.79 | 55.2 |
Total Current Liabilities | 1,331 | 612.56 | 377.92 | 376.63 | 369.65 |
Long-Term Debt | 28.84 | 233.32 | 35.42 | 30.59 | 40.8 |
Pension & Post-Retirement Benefits | 6.4 | 5.48 | 3.82 | 3.16 | 2.84 |
Long-Term Deferred Tax Liabilities | - | - | 0.63 | 2.98 | -1.01 |
Other Long-Term Liabilities | -0 | 0 | - | - | - |
Total Liabilities | 1,366 | 851.36 | 417.79 | 413.36 | 412.28 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 130.38 | 104.4 | 104.4 | 76.8 | 20 |
Additional Paid-In Capital | - | 189.42 | 189.42 | - | - |
Retained Earnings | - | 335.18 | 254.77 | 156.77 | 111.48 |
Comprehensive Income & Other | 1,246 | 2.74 | 0 | - | - |
Shareholders' Equity | 1,376 | 631.73 | 548.58 | 233.57 | 131.48 |
Total Liabilities & Equity | 2,743 | 1,483 | 966.37 | 646.93 | 543.76 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 496.65 | 310.3 | 67.53 | 71.19 | 97.38 |
Net Cash (Debt) | -58.28 | -214.83 | 64.18 | 13.37 | -39.12 |
Net Cash Growth | - | - | 379.93% | - | - |
Net Cash Per Share | -4.79 | -20.58 | 6.45 | 1.80 | -7.60 |
Filing Date Shares Outstanding | 12.43 | 10.44 | 10.44 | 7.68 | 2 |
Total Common Shares Outstanding | 12.43 | 10.44 | 10.44 | 7.68 | 2 |
Working Capital | 593.23 | 275.4 | 315.04 | 90.51 | 6.58 |
Book Value Per Share | 110.71 | 60.51 | 52.55 | 30.41 | 65.74 |
Tangible Book Value | 1,376 | 631.73 | 548.58 | 233.57 | 131.48 |
Tangible Book Value Per Share | 110.71 | 60.51 | 52.55 | 30.41 | 65.74 |
Land | - | 121.46 | 10.11 | 10.11 | 10.11 |
Buildings | - | 166.53 | 84.93 | 53.66 | 48.76 |
Machinery | - | 183.74 | 145.27 | 122.85 | 104.25 |
Construction In Progress | - | 118.82 | - | - | - |